Not all AI or regression models are the same, nor do they all incorporate the same data when assessing patient risk.

Trial results thus far indicate the drug can significantly extend progression-free survival compared to current standard of care treatments.

By giving providers greater insight into a tumor’s molecular footprint, the method could also reduce the need for invasive biopsies.

These findings may lead to new screening guidelines that could change how imaging is utilized in the aging population.

About 282 (or 1%) of radiologists worked for PE entities in 2013, a number that has increased over 1,300% in the 11 years since, according to new research. 

SCAI President James Hermiller, Jr., MD, explains the need for more innovative radiation protection systems in the cath lab.

If U.S. healthcare is to help advance responsible and ethical AI for all communities, it very much needs to continue prioritizing DEI initiatives.